Clinical trial: dose-dependent therapeutic efficacy of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia - 100 mg t.i.d. is an optimal dosage: Acotiamide in functional dyspepsia
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Acotiamide is a selective acetylcholinesterase inhibitor and enhances the actions of cholinergic neurons localized in the stomach. METHODS: The present two studies were conducted to examine the optimal dosage of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia (FD) in Japan. KEY RESULTS: The improvement rate of 'subjects global assessment of overall treatment efficacy (OTE)' at the final evaluation was approximately 10% higher in the acotiamide 100 mg group than that in the placebo group with good reproducibility though there was no significant differences at primary endpoint. The elimination rate of postprandial fullness in the acotiamide 100 mg group was significantly higher compared to placebo group. In addition, the post hoc analysis showed that in patients whose main complaints are meal-related symptoms such as postprandial fullness, upper abdominal bloating and/or early satiety, the improvement rate of 'OTE' at final evaluation in acotiamide 100 mg group was significantly superior to that in the placebo group. CONCLUSIONS & INFERENCES: These results suggest that acotiamide possesses efficacy on FD and more specifically its meal-related symptoms of FD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional Gastroduodenal Disorders
Tack, J., Talley, N. J., Camilleri, M., Holtmann, G., Hu, P., Malagelada, J.-R., & Stanghellini, V. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.059 · Cited by 2,418
Self-citationClinical trial guidelines for pharmacological treatment of irritable bowel syndrome
Corazziari, E., Bytzer, P., Delvaux, M., Holtmann, G., Malagelada, J. R., Morris, J., Muller‐Lissner, S., Spiller, R. C., Tack, J., & Whorwell, P. J. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01709.x · Cited by 80
Self-citation
Cited by
ACG and CAG Clinical Guideline: Management of Dyspepsia
Moayyedi, P. M., Lacy, B. E., Andrews, C. N., Enns, R. A., Howden, C. W., & Vakil, N. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2017.154 · Cited by 689
Functional dyspepsia—symptoms, definitions and validity of the Rome III criteria
Tack, J., & Talley, N. J. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.14 · Cited by 276
Self-citationReview article: current treatment options and management of functional dyspepsia
Lacy, B. E., Talley, N. J., Locke, G. R., Bouras, E. P., DiBaise, J. K., El‐Serag, H. B., Abraham, B. P., Howden, C. W., Moayyedi, P., & Prather, C. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05128.x · Cited by 192
Dyspepsia: Organic Versus Functional
Oustamanolakis, P., & Tack, J. (2012) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e318241b335 · Cited by 146
Self-citationRome Foundation Endpoints and Outcomes Conference 2009: Optimizing Clinical Trials in FGID
Chang, L., & Drossman, D. A. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.49 · Cited by 22
Metadata
- Authors
- Matsueda, K., Hongo, M., Tack, J., Aoki, H., Saito, Y., & Kato, H.
- Venue
- Neurogastroenterology & Motility
- Publisher
- Wiley
- Published
- 2010-01-05
- Volume
- 22
- Issue
- 6
- Pages
- 618-e173
- ISSN
- 1350-1925 (ISSN-L)
- 1365-2982
- OpenAlex
- W2098545746
- Cited by
- 130
- References
- 2
- FWCI
- 9.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical trial: dose-dependent therapeutic efficacy of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia - 100 mg t.i.d. is an optimal dosage: Acotiamide in functional dyspepsia. https://app.cochat.ai/papers/10.1111/j.1365-2982.2009.01449.x
- The paper
- Matsueda, K., Hongo, M., Tack, J., Aoki, H., Saito, Y., & Kato, H. (2010). Clinical trial: dose-dependent therapeutic efficacy of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia - 100 mg t.i.d. is an optimal dosage: Acotiamide in functional dyspepsia. Neurogastroenterology & Motility. https://doi.org/10.1111/j.1365-2982.2009.01449.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.